REFERENCES 1. Kempe A, Saville AW, Albertin C, et al. Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey. Pediatrics 2020;146. 2. Choi SH, Jo YH, Jo KJ, et al. Pediatric and Parents’ Attitudes Towards COVID-19 Vaccines and Intention to Vaccinate for Children. J Korean Med Sci 2021;36:e227. 3. Kim C, Yee R, Bhatkoti R, et al. COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022. MMWR Morb Mortal Wkly Rep 2022;71:378-83. 4. Gray A, Fisher CB. Determinants of COVID-19 Vaccine Uptake in Adolescents 12-17 Years Old: Examining Pediatric Vaccine Hesitancy Among Racially Diverse Parents in the United States. Front Public Health 2022;10:844310. 5. He K, Mack WJ, Neely M, et al. Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy. J Community Health 2022;47:39-52. 6. Bogiatzopoulou, Aliki et al. “COVID-19 in children: what did we learn from the first wave?.” Paediatrics and child health vol. 30,12 (2020): 438-443. doi:10.1016/j.paed.2020.09.005 ■
Physicians should thus work towards having continuous conversations that are changing subsequent to new data and developments of new worries or fears in society. Static stances and opinioned cannot be assumed or expected of families. While our study shows that for COVID-19, parents are hesitant to accept the vaccine because of lack of sureness in its efficacy, providers should not anticipate that this will be a permanent fear for this vaccine or for other vaccines pertaining to and not pertaining to this particular disease. The findings of this survey can be further extrapolated to other vaccines and hesitancy in future vaccines by providers being willing to be adaptable to the patient and their particular set of circumstances that are ever changing due to a multitude of factors. Moving forward, further research and surveying should be conducted assessing parents’ hesitancy and acceptance of the COVID-19 vaccine now that it has been widely distributed. Researchers may now assess how parents’ opinions may have changed on the vaccine as it becomes more normalized and accessed. Future surveys may be conducted on new vaccines, whether they be for COVID-19 or for other diseases to see how parents’ worries or confidence are different based on the type of disease the vaccine has been created for, the dangers that specific disease poses, and how widespread the impact of that disease is on the general population. A study surveying a larger number of individuals may also be more telling and may show if demographics significantly shift a respondent’s survey answers. Further similar studies should be conducted to continue learning how pediatric providers can best discuss and educate parents on vaccines for pediatric patients.
MULTI-EMPLOYER 401(K) PLAN INTRODUCING THE CHECK OUT THIS NEW BENEFIT!
THE LSMS HAS BEEN WORKING TIRELESSLY WITH OUR PARTNER ACG WEALTH TO DEVELOP A MULTI EMPLOYER LSMS 401 K PLAN, WHICH OFFERS THE FOLLOWING BENEFITS TO YOU:
INSTITUTIONAL LEVEL PRICING FOR BOTH ADMINISTRATION AND INVESTMENTS
REDUCED FIDUCIARY LIABILITY FOR THE PRACTICE
$
PHYSICIAN FOCUSED INVESTMENT ALTERNATIVES
ELIMINATION OF AUDIT REQUIREMENTS
$
ELIMINATION OF ONE PHYSICIAN BEING NAMED AS PLAN “TRUSTEE”
Kevin Rainwater, ACG Wealth krainwater@acgwealth.com 404.991.7060
FOR MORE INFORMATION:
25
J LA MED SOC | VOL 174 | FALL 2022
Made with FlippingBook Digital Publishing Software